Home / Recalls / Wells Pharmacy Network LLC / D-0356-2017

D-0356-2017 Class II Terminated

Recalled by Wells Pharmacy Network LLC — Ocala, FL

Recall Details

Product Type: Drugs
Report Date: January 11, 2017
Initiation Date: September 21, 2016
Termination Date: July 2, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 203 kits (number of vials per kit vary by prescription)

Product Description

Fluorescein/Indocyanine, Lyophilized (P.F.), 400 mg/15 mg, 1 mL, Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide

Code Information

All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known kit lot code: 06082016@133. Known vial lot code: 05202016@4.

Other recalls by Wells Pharmacy Network LLC

D-0364-2017 Class II — Leucine/Isoleucine/Valine 10 mg/10 mg/5 mg/5 mg/mL Injectable, 30 mL vial, Compo (September 21, 2016)
D-0327-2017 Class II — Testosterone Cypionate in Grapeseed Oil Injectable, 200 mg/mL, a) 1 mL b) 3 mL c (September 21, 2016)
D-0344-2017 Class II — Carnitine-L 250 mg/mL Injectable, 30 mL vials, Rx only, Compounded by Wells Pha (September 21, 2016)
D-0389-2017 Class II — Sermorelin Acetate/GHRP (2) & (6) 9 mg/3.15 mg/3.15 mg Injectable Kit, Compounde (September 21, 2016)
D-0421-2017 Class II — Vitamin D3 in Sesame Oil Injectable 50,000 IU/mL, 5 mL vial, Compounded by Wells (September 21, 2016)
D-0376-2017 Class II — MIC+B12(M)+Carnitine 12.5 mg/50 mg/100 mg/1 mg/50 mg/mL Injectable, 30 mL vial, (September 21, 2016)
D-0343-2017 Class II — Bimix 30 mg/1 mg/mL Injectable, a) 5 mL and b) 10 mL vial, Compounded by Wells P (September 21, 2016)
D-0334-2017 Class II — ULTRA-TEST in Grapeseed Oil (CYP 90%/PROP 10%) Injectable, 200 mg/mL, 8 mL vial, (September 21, 2016)
D-0331-2017 Class II — Phenylephrine HCl Injectable, 1 mg/mL (0.1%), 5 mL vial, Compounded by Wells Pha (September 21, 2016)
D-0371-2017 Class II — MIC/BCOMP+CAR+ARG+CHR+LID 12.5 mg/25 mg/25 mg/25 mg/12.5 mg/0.2 mg/20 mg/mL Inje (September 21, 2016)